Beam Therapeutics, Inc. (BEAM)
27.93
-1.60
(-5.42%)
USD |
NASDAQ |
May 15, 16:00
27.90
-0.03
(-0.11%)
After-Hours: 20:00
Beam Therapeutics Total Liabilities (Quarterly) : 316.36M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 137.84M |
| Twist Bioscience Corp. | 221.12M |
| Recursion Pharmaceuticals, Inc. | 314.75M |
| Anika Therapeutics, Inc. | 45.49M |
| BioCryst Pharmaceuticals, Inc. | 1.019B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.481B |
| Shareholders Equity (Quarterly) | 1.164B |
| Debt to Equity Ratio | 0.2154 |
| Current Ratio | 16.99 |
| Net Debt Paydown Yield | -0.73% |